Very early researchNot Yet RecruitingNCT07458919What this trial is testingTherapy for Advanced NSCLC With EGFR 19delins MutationWho this might be right forLung Cancer Fuzhou General Hospital 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT02657551What this trial is testingA Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid CancerWho this might be right forThyroid Cancer Dana-Farber Cancer Institute 8
Large-scale testing (Phase 3)Ended earlyNCT03626545What this trial is testingPhase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line TherapyWho this might be right forNon-Small-Cell Lung Novartis Pharmaceuticals 245
Post-approval studies (Phase 4)Study completedNCT05840445What this trial is testingEfficacy of Prabotulinum and Onabotulinum Toxin-A for Facial WrinklesWho this might be right forFaceSkin FoldRejuvenation Instituto de Oftalmología Fundación Conde de Valenciana 26
Testing effectiveness (Phase 2)UnknownNCT05438706What this trial is testingA Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast CancerWho this might be right forTriple-negative Breast Cancer Fudan University 70
Large-scale testing (Phase 3)Looking for participantsNCT06194734What this trial is testingKC1036 Versus Investigator's Choice of Chemotherapy in Patients With Advanced Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Beijing Konruns Pharmaceutical Co., Ltd. 490
Testing effectiveness (Phase 2)Study completedNCT00105092What this trial is testingEnzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.Who this might be right forNon-Small-Cell Lung Carcinoma Eli Lilly and Company 50
Large-scale testing (Phase 3)Study completedNCT02031744What this trial is testingThe Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 530
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07413601What this trial is testingPhase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC)Who this might be right forTriple Negative Breast Cancer Metastatic Cancer Institute and Hospital, Chinese Academy of Medical Sciences 78
Testing effectiveness (Phase 2)Ended earlyNCT03622931What this trial is testingPatients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO GuidelinesWho this might be right forOvarian Cancer Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)Study completedNCT00054119What this trial is testingKarenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerWho this might be right forPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma Gynecologic Oncology Group 27
Not applicableNot Yet RecruitingNCT05928312What this trial is testingFruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal CancerWho this might be right forAdvanced Colorectal Cancer Zhejiang Cancer Hospital 72
Not applicableStudy completedNCT05117918What this trial is testingOveractive Bladder Telemedicine Non-inferiority TrialWho this might be right forOveractive Bladder University of California, Los Angeles 177
Testing effectiveness (Phase 2)Looking for participantsNCT06485713What this trial is testingEfficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRCWho this might be right forMetastatic Colorectal CancerDrug Therapy First Affiliated Hospital of Wenzhou Medical University 200
Large-scale testing (Phase 3)Study completedNCT00080340What this trial is testingStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Carcinoma Telik 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609What this trial is testingInvestigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forAdvanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more Ascendis Pharma Oncology Division A/S 320
Early research (Phase 1)UnknownNCT05155124What this trial is testingSafety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRCWho this might be right forColorectal Neoplasms Malignant Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 6
Not applicableStudy completedNCT05475431What this trial is testingReal-world Treatment of H. Pylori Eradication in Patients with ComorbidityWho this might be right forHelicobacter Pylori InfectionComorbidities and Coexisting ConditionsReal-world Outcome+3 more National Cheng-Kung University Hospital 1,053
Large-scale testing (Phase 3)Study completedNCT01763671What this trial is testingPaclitaxel-bevacizumab in Advanced Lung CancerWho this might be right forNon-squamous Non-small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique 166
Not applicableEnded earlyNCT07421934What this trial is testingEvaluation of the Performance and Safety of a Linear Hyaluronic Acid-Based Medical Device in the Treatment of Surgical Wounds in the Oral Cavity.Who this might be right forPost-surgical Oral WoundsOral Cavity SurgeryWound Healing/Regeneration+3 more The Wave Innovation Group s.r.l. 28